Genomes and Genes
Gene Symbol: MGMT
Description: O-6-methylguanine-DNA methyltransferase
Alias: 6-O-methylguanine-DNA methyltransferase, O-6-methylguanine-DNA-alkyltransferase, O6-methylguanine-DNA methyltransferase, methylated-DNA--protein-cysteine methyltransferase, methylguanine-DNA methyltransferase
Publications236 found, 100 shown here
- MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patientsAlba A Brandes
Department of Medical Oncology, Bellaria Maggiore Hospital, Azienda Unità Sanitaria Locale of Bologna, Bologna, Italy
J Clin Oncol 26:2192-7. 2008..The radiologic images obtained in this setting can be difficult to interpret since they may show radiation-induced pseudoprogression (psPD) rather than disease progression...
- The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomasVan Thang Cao
Brain Tumor Research Laboratory and Research Institute of Medical Sciences, Chonnam National University, Hwasun Hospital and Medical School, Gwangju, Republic of Korea
Neurosurgery 65:866-75; discussion 875. 2009The aim of this study was to evaluate the correlation and prognostic significance of MGMT promoter methylation and protein expression in patients with glioblastoma.
- Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomideMonika E Hegi
Laboratory of Tumor Biology and Genetics of the Neurosurgery Departments of the University Hospitals, Lausanne, Switzerland
Clin Cancer Res 10:1871-4. 2004..trial, we determined the predictive value of the methylation status of the O-6-methylguanine-DNA methyltransferase (MGMT) promoter for outcome in glioblastoma patients treated with the alkylating agent temozolomide...
- Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBMNameeta Shah
The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, Washington, United States of America
PLoS ONE 6:e16146. 2011O⁶-methylguanine DNA-methyltransferase (MGMT) promoter methylation has been identified as a potential prognostic marker for glioblastoma patients...
- MGMT promoter hypermethylation in a series of 104 glioblastomasMarta Mellai
Neuro bio oncology Center of Policlinico di Monza Foundation, University of Turin, Via Pietro Micca, 29 13100 Vercelli, Italy
Cancer Genomics Proteomics 6:219-27. 2009To evaluate MGMT promoter hypermethylation as prognostic factor in a retrospective study of 104 cases of glioblastoma multiforme (GBM).
- O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylationSimone Kreth
Department of Anaesthesiology, Ludwig Maximilians University, Munich, Germany
PLoS ONE 6:e17156. 2011We analyzed prospectively whether MGMT (O(6)-methylguanine-DNA methyltransferase) mRNA expression gains prognostic/predictive impact independent of MGMT promoter methylation in malignant glioma patients undergoing radiotherapy with ..
- Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomideGiuseppe Minniti
Department of Radiation Oncology, Sant Andrea Hospital, University La Sapienza, Via di Grottarossa 1035, 00189, Rome, Italy
J Neurooncol 102:311-6. 2011Epigenetic silencing of the O(6)-methylguanine-DNA-methyltransferase (MGMT) gene by promoter methylation is correlated with improved progression-free survival (PFS) and overall survival (OS) in adult patients with newly diagnosed ..
- A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenograftsDeborah S Malley
Division of Molecular Histopathology, Department of Pathology, Level 3, Lab Block, Addenbrooke s Hospital, University of Cambridge, Cambridge, CB2 0QQ, UK
Acta Neuropathol 121:651-61. 2011O(6)-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair protein that removes alkyl DNA adducts such as those induced by alkylating agents...
- MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951Martin J van den Bent
Department of Neuro Oncology and Pathology, Daniel den Hoed Cancer Center and Erasmus University Medical Center, Rotterdam, The Netherlands
J Clin Oncol 27:5881-6. 2009O6-methylguanine-methyltransferase (MGMT) promoter methylation has been shown to predict survival of patients with glioblastomas if temozolomide is added to radiotherapy (RT)...
- The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastomaGulsah Cecener
Department of Medical Biology, School of Medicine, Uludag University, Bursa, Turkey
Cell Mol Neurobiol 32:237-44. 2012..We examined the methylation status at the promoter regions of GATA6, MGMT, and FHIT using the methylation-specific polymerase chain reaction in 61 primary GBMs...
- A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951Martin J van den Bent
Neuro Oncology Unit, Department of Neurology, Daniel den Hoed Cancer Center Erasmus Medical Center, Rotterdam, The Netherlands
Clin Cancer Res 17:7148-55. 2011The MGMT promoter methylation status has been suggested to be predictive for outcome to temozolomide chemotherapy in patients with glioblastoma (GBM)...
- Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomasJörg Felsberg
Department of Neuropathology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany
Int J Cancer 129:659-70. 2011Epigenetic silencing of the O(6) -methylguanine-DNA methyltransferase (MGMT) gene promoter is associated with prolonged survival in glioblastoma patients treated with temozolomide (TMZ)...
- MGMT methylation: a marker of response to temozolomide in low-grade gliomasSibille Everhard
Institut National de la Sante et de la Recherche Medicale, U711, Paris, France
Ann Neurol 60:740-3. 2006..0001). Assessment of MGMTP status could help identifying low-grade gliomas patients more likely to respond to chemotherapy or to benefit from MGMT depletion strategies.
- O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical courseTakao Watanabe
Department of Neurological Surgery, Nihon University School of Medicine, 30 1 Oyaguchi kamumachi, Itabashi ku, Tokyo 173 8610, Japan
Int J Cancer 113:581-7. 2005Epigenetic silencing of O(6)-methylguanine-DNA methyltransferase (MGMT) by promoter methylation can confer cancer cells with an increased sensitivity to alkylating chemotherapeutic agents and a higher susceptibility to TP53 transition ..
- RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTsAiala Lorente
Brain Tumor Biology Unit, University of Navarra, Irunlarrea 1, Pamplona, Spain
Brain Pathol 19:279-92. 2009..1) and BLU (3p21.3) have been shown to be downregulated by methylation in cancer, and PTEN (10q23.3) and MGMT (10q26.1) are located in areas commonly deleted in astrocytomas...
- O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implicationsAlba A Brandes
Department of Medical Oncology, Azienda USL Bellaria Maggiore Hospital, Bologna, Italy
Neuro Oncol 12:283-8. 2010O(6)-methylguanine DNA-methyltransferase (MGMT) promoter methylation status is a prognostic factor in newly diagnosed glioblastoma patients. However, it is not yet clear whether, and if so how, MGMT methylation status may change...
- Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a referenceLuca Morandi
Department of Haemathology and Oncological Sciences Section of Pathology, Bellaria Hospital, University of Bologna, Italy
BMC Cancer 10:48. 2010Epigenetic silencing of the MGMT gene by promoter methylation is associated with loss of MGMT expression, diminished DNA-repair activity and longer overall survival in patients with glioblastoma who, in addition to radiotherapy, received ..
- MGMT immunohistochemical expression and promoter methylation in human glioblastomaFausto J Rodriguez
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Appl Immunohistochem Mol Morphol 16:59-65. 2008O6-methylguanine-DNA methyltransferase (MGMT) expression has been recently proposed as a useful prognostic and/or predictive marker in glioblastoma patients receiving adjuvant therapy after the surgery...
- Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarkerMatthias Preusser
Department of Internal Medicine 1, Medial University of Vienna, Vienna, Austria
Brain Pathol 18:520-32. 2008Silencing of O6-methylguanine-DNA methyltransferase (MGMT) protein expression because of MGMT gene promoter hypermethylation is considered to be associated with postoperative chemoradiotherapy benefits in glioblastoma multiforme (GBM) ..
- Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomasEva M Grasbon-Frodl
Center for Neuropathology and Prion Research, Ludwig Maximilians Universitat Munchen, Munich, Germany
Int J Cancer 121:2458-64. 2007Hypermethylation of the DNA repair gene O(6)-methyl-guanine DNA methyltransferase (MGMT) has been linked to prolonged survival in glioblastoma patients treated with alkylating agents...
- Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomasJ L Blanc
Laboratory of Molecular Oncology, EA 2224, IBMIG, Poitiers, France
J Neurooncol 68:275-83. 2004In an effort to extend the potential relationship between the methylation status of MGMT promoter and response to CENU therapy, we examined the methylation status of MGMT promoter in 44 patients with glioblastomas...
- Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancerTetsuji Nakagawachi
Division of Molecular Biology and Genetics, Department of Biomolecular Sciences, Saga Medical School, 5 1 1 Nabeshima, Saga 849 8501, Japan
Oncogene 22:8835-44. 2003O6-methylguanine-DNA methyltransferase (MGMT) repairs the cytotoxic and mutagenic O6-alkylguanine produced by alkylating agents such as chemotherapeutic agents and mutagens...
- MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCRAnnette Bentsen Håvik
Section for Cancer Cytogenetics, Institute for Medical Informatics, Oslo University Hospital The Norwegian Radium Hospital, P, O, Box 4950 Nydalen, N 0424 Oslo, Norway
J Transl Med 10:36. 2012Methylation of the O(6)-methylguanine-DNA methyltransferase (MGMT) gene promoter is a favorable prognostic factor in glioblastoma patients...
- Interactions of human O(6)-alkylguanine-DNA alkyltransferase (AGT) with short double-stranded DNAsManana Melikishvili
Department of Molecular and Cellular Biochemistry and Center for Structural Biology, University of Kentucky, Lexington, Kentucky 40536, USA
Biochemistry 47:13754-63. 2008..High AGT densities resulting from cooperative binding may allow efficient search for lesions in the context of chromatin remodeling and DNA replication...
- Effects of zinc occupancy on human O6-alkylguanine-DNA alkyltransferaseJoseph J Rasimas
Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA
Biochemistry 42:980-90. 2003..Zinc also provides conformational stability to hAGT that may influence its regulation...
- The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesionsZhenhua Lin
Department of Pathology, Korea University College of Medicine, Seoul, South Korea
J Cancer Res Clin Oncol 131:364-70. 2005This study is aimed at investigating the significance of gene promoter methylation status and protein expression of p16 INK4A and O6-methylguanine-DNA methyltransferase (MGMT) in the various uterine cervical lesions.
- Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastomaKwong Wai Choy
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong, China
Neoplasia 7:200-6. 2005..changes of the RAS-associated domain family 1A (RASSF1A) gene and the O6-methylguanine-DNA methyltransferase (MGMT) gene in retinoblastoma...
- Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferaseYuanyuan Gao
Department of Pediatrics, Child and Family Research Institute, University of British Columbia, 950 West 28th Avenue, Vancouver, British Columbia, Canada V5Z 4H4
Mol Cancer Ther 8:3276-84. 2009..current dogma is that temozolomide resistance rests on the expression of O6-methylguanine-DNA methyltransferase (MGMT) because it cleaves methylated DNA adducts formed by the drug...
- Mutations that probe the cooperative assembly of O⁶-alkylguanine-DNA alkyltransferase complexesClaire A Adams
Center for Structural Biology, Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky 40536, United States
Biochemistry 50:1590-8. 2011..This is the first evidence, to the best of our knowledge, of a role for residues at the protein-protein interface and, by implication, cooperative protein-protein interactions in the cell-protective mechanisms of AGT...
- O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastomaReiko Watanabe
Division of Diagnostic Pathology, Shizuoka Cancer Center, Sunto, Shizuoka, Japan
Brain Tumor Pathol 28:127-35. 2011Expression of the O(6)-methylguanine-DNA methyltransferase (MGMT) gene has been shown to correlate with clinical outcomes in patients with glioblastoma multiforme treated with alkylating agents...
- Repair of O4-alkylthymine by O6-alkylguanine-DNA alkyltransferasesQingming Fang
Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA
J Biol Chem 285:8185-95. 2010..These results show that specific alterations in the hAGT active site facilitate efficient recognition and repair of O(4)-alkylthymines and reveal damage-dependent interactions of base and nucleotide excision repair...
- MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk studyYet Hua Loh
MRC Centre for Nutritional Epidemiology in Cancer Prevention and Survival, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, United Kingdom
DNA Repair (Amst) 9:421-8. 2010O(6)-Methylguanine-DNA methyltransferase (MGMT) repairs DNA damage caused by alkylating agents including N-nitroso compounds from diet...
- The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for gliomaFumiharu Ohka
Department of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan
PLoS ONE 6:e23332. 2011..Although GBM patients benefit from promoter hypermethylation of the O(6)-methylguanine-DNA methyltransferase (MGMT) that is the main determinant of resistance to TMZ, recent studies suggested that MGMT promoter methylation is of ..
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaAndreana L Rivera
Departments of Pathology and Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0097, Houston, TX 77030, USA
Neuro Oncol 12:116-21. 2010Hypermethylation of the O(6)-methylguanine-DNA-methyltransferase (MGMT) gene has been shown to be associated with improved outcome in glioblastoma (GBM) and may be a predictive marker of sensitivity to alkylating agents...
- Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesionsXiao Ping Zou
Department of Gastroenterology, The Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing 210008, PR China
Hum Pathol 40:1534-42. 2009..In this study, we determined the methylation frequency of 5 genes, including p16, Runx3, MGMT, DAPK, and RASSF1A, by methylation-specific polymerase chain reaction, in a series of formalin-fixed paraffin-..
- DNA repair gene O6-methylguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumorsDong Yin
Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, California 90048, USA
Mol Carcinog 36:23-31. 2003The DNA repair enzyme O(6)-methylguanine-DNA methyltransferase (MGMT) removes alkylating adducts from the O(6) position of guanine and protects cells from cytotoxic and mutagenic effects...
- Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approachDavid Capper
Institute of Brain Research, University of Tubingen, Tubingen, Germany
Acta Neuropathol 115:249-59. 2008Immunohistochemical studies showed that O(6)-methylguanine-DNA methyltransferase (MGMT) protein expression is negatively associated with survival in glioblastomas treated with alkylating agents in accordance with previous results of ..
- Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various gradesIris Lavon
Gaffin Center for Neuro Oncology and the Department of Neurology, Hadassah Hebrew University Medical Center, Ein Kerem, PO Box 12000, Jerusalem 91120, Israel
Neuro Oncol 12:173-80. 2010..The methylation status of O(6)-methyl guanine methyltransferase (MGMT) and phosphatase and tensin homolog promoters was studied by methylation-specific PCR...
- MGMT prognostic impact on glioblastoma is dependent on therapeutic modalitiesEmmanuelle Criniere
INSERM, U711, Biologie des Interactions Neurones and Glie, Universite Pierre et Marie Curie, Faculte de Medecine, Paris, France
J Neurooncol 83:173-9. 2007b>MGMT promoter methylation, which has been correlated with the response to alkylating agents, was investigated in a retrospective series of 219 glioblastomas (GBMs) treated with various modalities...
- Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosaKeizo Kato
Department of Oral and Maxillofacial Sciences, Graduate School of Medicine, Gifu University, 1 1 Yanagido, Gifu, 501 1194, Japan
J Cancer Res Clin Oncol 132:735-43. 2006..Recent studies have shown roles of promoter hypermethylation of tumor suppressor genes, including p16 and MGMT, in several types of cancers...
- Determination of the methylation status of MGMT in different regions within glioblastoma multiformeMark G Hamilton
Division of Neurosurgery, Department of Clinical Neurosciences, University of Calgary, Foothills Hospital 12th Floor 1403 29 ST NW 1195, Calgary, AB, T2N 2T9, Canada
J Neurooncol 102:255-60. 2011Epigenetic silencing of the MGMT gene through promoter methylation correlates with improved survival in Glioblastoma Multiforme (GBM) patients receiving concurrent chemoradiotherapy...
- Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancerBo Bin Lee
Molecular Cell Biology, Samsung Medical Center, Seoul, Korea
Clin Cancer Res 15:6185-91. 2009..To identify epigenetic molecular makers in plasma for the early detection of colorectal cancer...
- Interactions of human O6-alkylguanine-DNA alkyltransferase (AGT) with short single-stranded DNAsJoseph J Rasimas
Department of Molecular Physiology, Penn State University College of Medicine, Hershey, Pennsylvania 17033, USA
J Biol Chem 282:3357-66. 2007..We hypothesize that modest binding cooperativity and high binding densities are adaptations that allow AGT to efficiently search for lesions in the context of chromatin remodeling and DNA replication...
- Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based studyIzabela Zawlik
International Agency for Research on Cancer, Lyon, France
Neuroepidemiology 32:21-9. 2009O(6)-methylguanine-DNA methyltransferase (MGMT) is a repair enzyme that removes promutagenic O(6)-methylguanine adducts in DNA, to protect cells from acquisition of G:C--> A:T mutations...
- MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosisMeenakshi Sawhney
Department of Biochemistry, All India Institute for Medical Sciences, Ansari Nagar, New Delhi 110 029, India
Oral Oncol 43:515-22. 2007..O(6)-methylguanine-DNA methyltransferase (MGMT) is an enzyme that removes mutagenic adducts from the O(6) position of guanine, thereby protecting the genome ..
- O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastomaYukihiko Sonoda
Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1 1 Seiryo machi, Aoba ku, Sendai 980 8574, Japan
Int J Clin Oncol 15:352-8. 2010The prognostic significance of O(6)-methylguanine DNA methyltransferase (MGMT) was evaluated by analysis of both MGMT promoter methylation and protein expression in a series of patients with newly diagnosed glioblastoma.
- High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutationsEmilia Jesien-Lewandowicz
Department of Radiation Oncology, Chair of Oncology, Copernicus Memorial Hospital, Lodz, Poland
Cancer Genet Cytogenet 188:77-82. 2009O(6)-methylguanine DNA methyltransferase (MGMT) reduces cytotoxicity of therapeutic or environmental alkylating agents...
- Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteinsRebecca P Danam
Department of Molecular Pharmacology, St Jude Children s Research Hospital 332 North Lauderdale Memphis, TN 38105, USA
Mol Cancer Ther 4:61-9. 2005Transcriptional silencing of the DNA repair gene, O6-methylguanine-DNA methyltransferase (MGMT) in a proportion of transformed cell lines is associated with methylated CpG hotspots in the MGMT 5' flank...
- Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patientsKai Tang
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No 6 Tiantan Xili 100050, Dongcheng District, Beijing, China
Med Oncol 29:1292-6. 2012Promoter methylation of O6-methylguanine-DNA methyltransferase (MGMT) gene has been considered as a prognostic maker and increasingly emphasized in the treatment of glioblastoma multiforme (GBM)...
- O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States)Gregory J Tranah
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
Cancer Causes Control 17:721-31. 2006O6-methylguanine-DNA methyltransferase (MGMT) removes mutagenic adducts from the O6-position of guanine in DNA. Unrepaired O6-methylguanines result in G:C to A:T transitions in mutated K-ras and p53 in colorectal tumors...
- Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumorsHamdy E Abouzeid
Radio Biological Applications Department, Nuclear Research Center, Atomic Energy Authority, Cairo, Egypt corrected
Tumour Biol 32:845-52. 2011..aim of the present study is the detection of methylation status for some tumor suppressor genes including RASSF1A, MGMT, and HIC-1 in both cancerous and precancerous lesions of colorectal mucosa to evaluate the possibility of ..
- Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back?Stephanie E Combs
Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
Radiat Oncol 6:115. 2011..treated with radiotherapy and temozolomide was analyzed for the impact of O6-methly-guanly-methyl-transferase (MGMT)-promoter methylation as well as isocitrate dehydrogenase (IDH)1-mutational status...
- Kinetic analysis of steps in the repair of damaged DNA by human O6-alkylguanine-DNA alkyltransferaseHong Zang
Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 0146, USA
J Biol Chem 280:30873-81. 2005..The results explain the overall patterns of rates of alkyl group removal versus AGT concentration and the effects of the mutations, as well as the greater affinity of AGT for DNA with O6-alkylG lesions...
- [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma]Heng Chuan Xue
Department of Thoracic Surgery, People s Hospital of Yangzhong, Yangzhong, Jiangsu, 212200, P R China
Ai Zheng 27:1256-62. 2008..This study was to investigate the association between aberrant hypermethylation of MGMT gene and clinical characteristics as well as MTHFR C677T genetic polymorphisms in esophageal squamous cell ..
- Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomasSibille Everhard
INSERM, U711, Batiment de la nouvelle Pharmacie, 47 bd de l Hopital, 75651 Paris Cedex 13, France
Neuro Oncol 11:348-56. 2009The O(6)-methylguanine-DNA methyltransferase gene (MGMT) is methylated in several cancers, including gliomas...
- Genetic polymorphisms of DNA repair genes and chromosomal damage in workers exposed to 1,3-butadieneQi Wang
Department of Occupational Health and Toxicology, School of Public Health, Fudan University, Key Laboratory of Public Health and Safety of Ministry of Education of China, Shanghai 200032, China
Carcinogenesis 31:858-63. 2010..pathway (x-ray repair cross-complementing group 1 (XRCC1) Arg194Trp, Arg280His, Arg399Gln, T-77C, ADPRT Val762Ala, MGMT Leu84Phe and APE1 Asp148Glu) and chromosomal damage in BD-exposed workers, using the cytokinesis-blocked (CB) ..
- O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsSabine Spiegl-Kreinecker
Department of Neurosurgery, Wagner Jauregg Hospital, Wagner Jauregg Weg 15, 4020 Linz, Austria
Neuro Oncol 12:28-36. 2010O(6)-Methylguanine DNA methyltransferase (MGMT) is implicated as a major predictive factor for treatment response to alkylating agents including temozolomide (TMZ) of glioblastoma multiforme (GBM) patients...
- Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferationEric Hervouet
Institut National de la Sante et de la Recherche Medicale U892, Centre de Recherche en Cancerologie, Equipe Apoptose et progression tumorale, Nantes, France
Clin Cancer Res 15:3519-29. 2009....
- Association between MGMT promoter hypermethylation and p53 mutation in glioblastomaJamal Shamsara
Biotechnology Research Center, Mashhad, Iran
Cancer Invest 27:825-9. 2009O(6)-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that removes alkyl groups from the O(6) position of guanine. MGMT is transcriptionally silenced by promoter hypermethylation in several human neoplasia...
- Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancersYasuo Koga
Department of Surgery, Saga University Faculty of Medicine, Nabeshima 5 1 1, Saga 849 8501, Japan
Ann Surg Oncol 12:354-63. 2005..demonstrated in an immunohistochemical study that reduced expression of O(6)-methylguanine-DNA methyltransferase (MGMT) correlated with a poorer prognosis in patients with biliary tract cancers...
- Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with K-ras G to A mutation in colorectal tumorJian Qi
Department of Gastroenterology, Zhongnan Hospital, Wuhan University, Wuhan 430071, Hubei Province, China
World J Gastroenterol 11:2022-5. 2005To investigate the functions of promoter hypermethylation of O6-methylguanine-DNA methyltransferase (MGMT) gene in colorectal tumorigenesis and progression.
- Is inactivation of O6-methylguanine DNA methyltransferase still a favorable prognostic factor of patients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy?Gyeong Won Lee
Division of Hematology Oncology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Republic of Korea
Leuk Lymphoma 50:1992-8. 2009The prognostic significance of O6-methylguanine DNA methyltransferase (MGMT) inactivation was evaluated in patients with diffuse large B-cell lymphoma (DLBCL) who received cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) ..
- O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancersPei Fang Wu
Graduate Institute of Clinical Medicine, National Taiwan University, College of Medicine, Taipei, Taiwan
Lung Cancer 68:484-90. 2010O(6)-Methylguanine-DNA methyltransferase (MGMT) is critical for repairing pro-mutagenic DNA bases and is correlated with response to alkylating agents in cancers...
- Detailed methylation patterns and protein expression profiles of MGMT in colorectal carcinoma surgical marginsDingdong Zhang
State Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, China
Clin Biochem 41:19-25. 2008..Hence, we examined MGMT expression profile and methylation status in histologically negative margins of colorectal cancer patients.
- Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutationsJeung Il Kim
Department of Orthopedics, School of Medicine, Pusan National University, Busan 602 739, Republic of Korea
Hum Pathol 40:934-41. 2009..methyltransferase protein expression status using immunohistochemistry and promoter hypermethylation of the MGMT gene using methylation-specific PCR...
- Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagusDoerthe Kuester
Department of Pathology, Otto von Guericke University Magdeburg, Germany
Cancer Lett 275:117-26. 2009To determine the relevance of MGMT in Barrett's carcinogenesis, we analyzed promotor hypermethylation and expression of MGMT in Barrett's adenocarcinomas and its paired precursor lesions from 133 patients using a methylation-specific PCR, ..
- Absence of MGMT promoter methylation in endometrial cancerB J Rimel
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, USA
Gynecol Oncol 112:224-8. 2009O(6)-methylguanine-DNA methyltransferase (MGMT) acts to repair DNA damaged by alkylation of guanine residues...
- Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanomaVerena Voelter
Centre Pluridisciplinaire d Oncologie, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
Int J Cancer 123:1215-8. 2008..Here, we investigated whether the DNA-repair-protein MGMT may be involved in the variability of response to fotemustine and temozolomide in uveal melanoma...
- Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South AfricaNirmitha I Herath
Leukaemia Foundation of Queensland, Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia
Oncol Rep 17:817-22. 2007The DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) is involved in cellular defences against alkylating agents...
- Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumorsBarbara Ingold
Department of Pathology, Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland
PLoS ONE 4:e4775. 2009The O(6)-methylguanine-methyltransferase (MGMT) promoter methylation status is a predictive parameter for the response of malignant gliomas to alkylating agents such as temozolomide...
- Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomasTakao Nakagawa
Department of Neurosurgery, Faculty of Medical Sciences, University of Fukui, Yoshida gun, Fukui, Japan
Neuropathology 29:379-88. 2009We studied the expression of O(6)-methylguanine-DNA methyltransferase (O(6)-MGMT), P-glycoprotein (Pgp), and multidrug resistance protein-1 (MRP-1) in 23 glioblastomas using RT-PCR, methylation-specific PCR, and immunohistochemistry, and ..
- Changes of the O6-methylguanine-DNA methyltransferase promoter methylation and MGMT protein expression after adjuvant treatment in glioblastomaTae Young Jung
Department of Neurosurgery, Chonnam National University Hwasun Hospital, Gwangju, Republic of Korea
Oncol Rep 23:1269-76. 2010The aim of this study was to evaluate variations of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and protein expression after adjuvant treatment in glioblastoma patients...
- Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphismIda L M Candiloro
Peter MaCallum Cancer Centre, St Andrew s Place, East Melbourne, Victoria 3002, Australia
Cancer Prev Res (Phila) 2:862-7. 2009Methylation of the CpG island in the MGMT promoter region is a frequent event in several cancer types including colorectal cancer, lung cancer, lymphoma, and glioblastoma...
- O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancerP Wolf
Department of Surgery, Medical College of Wisconsin, 601 Elmwood Avenue, Milwaukee, WI 53226, USA
Cancer Res 61:8113-7. 2001The DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) removes mutagenic adducts from the O6 position of guanine, thereby protecting the genome against G to A transition mutations...
- CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infectionS Matsukura
Department of Biochemistry, Saga Medical School, Japan
Br J Cancer 88:521-9. 2003Inactivations of DNA repair genes, O(6)-methylguanine-DNA methyltransferase (MGMT) and hMLH1, by promoter hypermethylation have been reported in several types of primary human neoplasia...
- Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patientsSun Hee Kim
Department of Pathology and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Mol Carcinog 37:32-8. 2003..To investigate whether O(6)-methylguanine-DNA methyltransferase (MGMT) is altered during colorectal carcinogenesis, we performed immunohistochemical staining on 265 sporadic colorectal ..
- Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre studyBruno M Costa
Life and Health Sciences Research Institute ICVS, Health Sciences School, University of Minho, Braga, Portugal
Oncol Rep 23:1655-62. 2010..The methylation status of the MGMT gene promoter is currently a promising molecular prognostic marker, but some controversial data have precluded its ..
- Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancerB Smith-Sørensen
Department of Tumour Biology, Institute for Cancer Research, The Norwegian Radium Hospital, 0310 Oslo, Norway
Oncogene 21:8878-84. 2002..A series of 70 tumours were analysed for methylation of CpG sites in the O(6)-methylguanine-DNA methyltransferase (MGMT) gene promoter, and in exon 1alpha of the cyclin-dependent kinase inhibitor 2A gene (CDKN2A)...
- MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastomaMarkus Christmann
Institute of Toxicology, University Medical Center Mainz, D 55131 Mainz, Germany
Int J Cancer 127:2106-18. 2010The DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT) is a key player in tumor cell resistance. Promoter methylation, MGMT activity and immunohistochemistry are used for determining the MGMT status...
- Prognostic significance of molecular markers and extent of resection in primary glioblastoma patientsJörg Felsberg
Department of Neuropathology, Heinrich Heine University, Dusseldorf, Germany
Clin Cancer Res 15:6683-93. 2009..Recent data indicate that certain molecular markers, in particular MGMT promoter hypermethylation, are associated with response to alkylating chemotherapy and longer survival...
- Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastomaJonathon F Parkinson
Cancer Genetics Group, Kolling Institute of Medical Research, University of Sydney, St Leonards, NSW 2065, Australia
J Neurooncol 87:71-8. 2008Methylation of the promoter region of the O ( 6 ) -methylguanine-DNA methyltransferase (MGMT) gene is known to be predictive of response to temozolomide treatment in patients with glioblastoma...
- Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brainJ R Silber
Department of Neurological Surgery, University of Washington, Seattle 98195
Cancer Res 53:3416-20. 1993We assayed the activity of the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) in 60 human brain tumors to assess the effects of tumorigenesis in brain on DNA repair capability. Activity was not detectable (< 0...
- Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysisKen Sasai
Laboratory of Molecular and Cellular Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Am J Surg Pathol 32:1220-7. 2008Evaluation of O6-methylguanine-DNA methyltransferase (MGMT) expression is important for antiglioma therapy as many clinical trials have demonstrated that promoter hypermethylation and low level expression of MGMT are associated with an ..
- Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancerEdward J Fox
Department of Pathology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
J Mol Diagn 8:68-75. 2006..Transcriptional silencing of O6-methylguanine DNA methyltransferase (MGMT) has also been described in a variety of neoplasms and has been associated with a consequent ..
- Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumorsMaria Möllemann
Department of Neuropathology, Heinrich Heine University, Dusseldorf, Germany
Int J Cancer 113:379-85. 2005..The DNA repair enzyme O(6)-methylguanine DNA methyltransferase (MGMT) may cause resistance to DNA-alkylating drugs commonly used in the treatment of anaplastic ..
- Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: comparison with sporadic colonic tumorsTetuo Mikami
Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan
Am J Clin Pathol 127:366-73. 2007..to genesis of ulcerative colitis (UC)-associated tumors, promoter methylation and expression of O6-methylguanine DNA methyltransferase (MGMT), hMLH1, p16INK4, and E-cadherin were examined in 14 low-grade dysplasias (LGDs), 15 high-..
- Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in gliomaIlse Vlassenbroeck
OncoMethylome Sciences SA, Tour 5 GIGA B34, 3, Avenue de l Hôpital 11, 4000 Liege, Belgium
J Mol Diagn 10:332-7. 2008Epigenetic silencing of the DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT) by promoter methylation predicts successful alkylating agent therapy, such as with temozolomide, in glioblastoma patients...
- Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinomaJianming Wang
Department of Epidemiology, School of Public Health, Fudan University, 138 Yi Xue Yuan Road, Shanghai, China
Cancer Epidemiol Biomarkers Prev 17:118-25. 2008To explore the role of aberrant hypermethylation of cancer-related genes, such as P16, MGMT, and hMLH1, in the esophageal squamous cell carcinoma (ESCC) as well as its relation to dietary folate intake and MTHFR C677T polymorphism, we ..
- Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosoureaK S Srivenugopal
Department of Experimental Pediatrics, University of Texas M D Anderson Cancer Center, Houston 77030, USA
Biochemistry 35:1328-34. 1996..the role of ubiquitination in the disposition of the inactivated O6-methylguanine-DNA methyltransferase (MGMT) protein in human (HT-29 and CEM) and murine (ts85) tumor cells...
- Aberrant methylation and loss of expression of O-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinomaOsamu Furonaka
Department of Pathology, Graduate School of Biomedical Sciences, Hiroshima University, Minami, Hiroshima, Japan
Pathol Int 55:303-9. 2005O(6)-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair protein that protects cells against the carcinogenic effects of alkylating agents...
- O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapiesKen Sasai
Laboratory of Molecular and Cellular Pathology, Hokkaido University Graduate School of Medicine, Kita ku, Sapporo, Japan
Mol Cancer 6:36. 2007..However, expression of O6-methylguanine-DNA methyltransferase (MGMT) renders glioma cells resistant to the treatment, indicating that identification of mechanisms underlying the gene ..
- Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesisTakeshi Nagasaka
Department of Gastroenterological Surgery and Surgical Oncology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
Int J Cancer 122:2429-36. 2008O(6)-methylguanine-DNA methyltransferase (MGMT) is a DNA repair gene which is frequently methylated in colorectal cancer (CRC)...
- Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer casesTakeshi Nagasaka
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
Clin Cancer Res 9:5306-12. 2003Because O(6)-methylguanine-DNA methyltransferase (MGMT) plays an essential role in repairing DNA damage caused by environmental alkylating chemicals, we were interested in determining whether we could see any obvious changes in the ..
- Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy onlyH De Schutter
Leuvens Kanker Instituut, UH Leuven Campus Gasthuisberg, 3000 Leuven, Belgium
Oncol Rep 21:507-13. 2009..the incidence and prognostic value of the promoter hypermethylation of TIMP3, CDH1, DAPK, RASSF1A, p16INK4A and MGMT in HNSCC treated solely by radiotherapy...
- Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanomaM Rastetter
AWG Tumour Genetics of the Medical Faculty, Martin Luther University Halle Wittenberg, Germany
Histol Histopathol 22:1005-15. 2007..genes in melanoma, we analyzed the intra-tumoural distribution of promoter methylation of RASSF1A, p16, DAPK, MGMT, and Rb in 339 assays of 34 tumours (15 melanoma primaries, 19 metastases) by methylation-specific PCR, correlation ..
- Folate deficiency alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no effect on genome-wide DNA methylationSusan J Duthie
Rowett Institute of Nutrition and Health, University of Aberdeen, United Kingdom
Cancer Prev Res (Phila) 3:92-100. 2010..diet for 24 weeks on DNA damage (8-oxo-7,8-dihydroguanine), DNA repair [O(6)-methylguanine-DNA methyltransferase (MGMT) and 8-oxoguanine-DNA glycosylase (OGG-1) activity], and epigenetic parameters (genome-wide cytosine methylation ..
- Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3Thierry Gorlia
EORTC Data Centre, Brussels, Belgium
Lancet Oncol 9:29-38. 2008....
- DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, ChinaWen Jing Ma
Medical Research Center, The First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China
World J Gastroenterol 16:641-7. 2010..To investigate the role of metabolic enzyme and DNA repair genes in susceptibility of esophageal squamous cell carcinoma (ESCC)...
- O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell linesMichael S Bobola
Division of Neurosurgery, Department of Surgery and Hematology Oncology, Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
Clin Cancer Res 11:2747-55. 2005..Our purpose is (a) to assess the contribution of the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) to the resistance of pediatric brain tumor cell lines to clinical alkylating agents and (b) to evaluate variables ..
- MGMT analysis at DNA, RNA and protein levels in glioblastoma tissueMatthias Preusser
Department of Internal Medicine I, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
Histol Histopathol 24:511-8. 2009..the epigenetic, transcriptional and translational regulation and expression of O6-methylguanine-methyltransferase (MGMT) is relevant for prognostic and predictive considerations in glioblastoma patients...
- Both base excision repair and O6-methylguanine-DNA methyltransferase protect against methylation-induced colon carcinogenesisStefan Wirtz
Department of Molecular Medicine, University of Erlangen Nuremberg, D 91052 Erlangen, German
Carcinogenesis 31:2111-7. 2010..The lesions are repaired by O(6)-methylguanine-DNA methyltransferase (Mgmt) and by enzymes of the base excision repair (BER) pathway, respectively...
- Modulation of DNA methylation status by dietary zinc: role in cancer preventionLOUISE FONG; Fiscal Year: 2009..in regulatory regions of specific genes, including the tumor suppressor genes CDKN2A and FHIT, the repair gene MGMT, and the stress-inducible gene MT-1;and B) if the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine can ..
- Pesticide Exposure and DNA Methylation in Pesticide ApplicatorsJENNIFER ANN RUSIECKI; Fiscal Year: 2010..region methylation for four of the most commonly silenced genes in cancers of concern to this cohort, p16INK4, MGMT, CDH-1, and GSTp1...
- Gene Targeted Therapy of Brain TumorsJohn H Sampson; Fiscal Year: 2010..This proposal tests this "personalized" medicine approach in human tumors grown in mice as a prelude to human clinical studies. ..
- DNA repair-based models of glioblastoma response to radiation and temozolomideJOHN SILBER; Fiscal Year: 2009..developed marker, or the biochemical activity, of the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT)...
- Role of Promotor Polymorphisms of the MGMT Gene in Alkylation ChemotherapySherif Z Abdel Rahman; Fiscal Year: 2010..O6-AG is repaired by the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT), and, therefore, MGMT levels constitute a critical factor in determining tumor resistance to TMZ treatment...
- Effect of dietary components on DNA repairMichael Wyatt; Fiscal Year: 2004..pathways, including Base Excision Repair (BER), mismatch DNA repair (MMR), and methylguanine DNA-methyltransferase (MGMT), in the response to alkylating agent-induced DNA damage; and 2) the effect of dietary constituents on these DNA ..
- DNA REPAIR DEFECTS AFFECTING HEMATOPOIETIC STEM CELLSStanton Gerson; Fiscal Year: 2005..methyl DNA adduct repair are mismatch repair [MMR] and 06-alkylguanine-DNA alkyltransferase [AGT], encoded by the MGMT gene...
- COMBATING ALKYLATING AGENT RESISTANCE IN HUMAN GLIOMASJOHN SILBER; Fiscal Year: 2002..agents is based on a mechanism(s) in addition to the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT)...
- NEOPLASTIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASEStephen Meltzer; Fiscal Year: 2007..including E-cadherin (CDH 1), p 16, p 15, p 14-ARF, death-associated protein kinase (DAPK), O6-methylguanine DNA methyltransferase (MGMT), human mutL homolog 1 (hMLH 1), adenomatous polyposis coli (APC), RASSF1A, deleted in colon ..
- TUMOR SUPPRESSOR GENE METHYLATION IN LUNG ADENOCARCINOMASteven A Belinsky; Fiscal Year: 2010..Transient transfection of minimized promoters into cell lines with an endogenously active or silenced gene will be used to elucidate the sequence of changes involved in repression of promoter activity. REVISED: July 7, 2005 ..
- Gene Methylation and Therapeutic Response in Lung CancerSteven Belinsky; Fiscal Year: 2005..identified two excellent biomarkers, the p16 tumor suppressor gene and the O6-methylguanine-DNA methyltransferase (MGMT) repair gene, whose inactivations through aberrant CpG island promoter hypermethylation occur frequently and early ..
- Promoter Specific Hypermethylation Sensors for Early Cancer DetectionIndraneel Ghosh; Fiscal Year: 2011..constructs;and 2) designing and testing biosensors that target promoter regions of genes (BRCA1, CDH1, p15, p16, MGMT, GSTp1) implicated in cancer...